Alvin Luk is a biotech executive, neuroscientist and entrepreneur with more than three decades in global drug development. He is President & Chief Medical Officer (Group) and U.S. CEO of HanchorBio, a clinical-stage immunology and immuno-oncology company building Fc-based designer biologics, and co-founder and CEO of CRISPR gene-editing company HuidaGene Therapeutics. Across his career he has contributed to roughly two dozen approved products and more than 250 global regulatory submissions, including LUXTURNA, the first FDA-approved gene therapy. A 2025 TIME100 Health honoree, he wants to turn HanchorBio into the 'Genentech of Asia.'
Dan Furman is a neuroscientist and the co-founder and CEO of Arctop, a company building the software intelligence layer that decodes human brain signals in real time from everyday wearables like headbands, earbuds and VR headsets. A Harvard-trained neurobiologist with a Technion PhD, he once helped adapt a sleep-monitoring device into a brain-computer interface for Stephen Hawking, and his doctoral work showed that non-invasive scalp sensors could control individual neuroprosthetic fingers. In 2023 Arctop raised a $10M Series A to apply its 'Brain ID' and real-time cognition technology across medicine, education, cybersecurity and entertainment.